Deaminet 2026: Breakthroughs in Base Editing, Deaminase Biology, and Therapeutic Translation (opens in new tab)

Deaminet 2026, held in Palm Springs in late January, brought together researchers studying deaminase enzymes across disciplines: from structural biologists resolving APOBEC proteins at atomic resolution, to cancer biologists dissecting mutational processes, to medical researchers advancing base and prime editing toward the clinic. Across talks spanning mechanism, off-target biology, and in vivo delivery, one theme stood out clearly: as our understanding of how these editors work deepens, the ...